DNTTIP2 Expression is Associated with Macrophage Infiltration and Malignant Characteristics in Low-Grade Glioma
,,
DOI: https://doi.org/10.2147/PGPM.S356326
2022-03-25
Pharmacogenomics and Personalized Medicine
Abstract:Yuan-Jie Liu, 1, 2, &ast Shu-hong Zeng, 2, 3, &ast Wei-hua Qian, 1 Min-xian Tao, 1 Ying-ying Zhu, 4 Jie-pin Li 1– 3 1 Department of Oncology, Zhangjiagang TCM Hospital Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu, 215600, People's Republic of China; 2 Department of Oncology, Affiliated Hospital of Nanjing University of Chinese Medicine, Jiangsu Province Hospital of Chinese Medicine, Nanjing, Jiangsu, 210029, People's Republic of China; 3 No. 1 Clinical Medical College, Nanjing University of Chinese Medicine, Nanjing, Jiangsu, 210023, People's Republic of China; 4 Department of Oncology, Affiliated Aoyang Hospital of Jiangsu University, Zhangjiagang, Jiangsu, 215600, People's Republic of China &astThese authors contributed equally to this work Correspondence: Jie-pin Li, Email Purpose: Low-grade gliomas (LGG) are primary brain tumors that often affect predominantly young adults, which usually have a painless course, and have a longer survival period compared to patients with high-grade gliomas. Relatively established treatment options include surgery, radiotherapy, chemotherapy or combination therapy, as well as individualized management based on tumor location, histology, molecular features and patient characteristics. Due to the rapid development of targeted therapies, the development of new molecular targets is now a very promising research direction. Methods: We explored the diagnostic value, clinical relevance, and molecular function of deoxynucleotidyl transferase terminal-interacting proteins 2 ( DNTTIP2 ) in LGG using MethSurv, MEXPRESS, STRING, cBioPortal, Tumor Immunity Estimation Resource (TIMER) database, Gene Expression Profiling Interactive Analysis (GEPIA) databases. Besides, the "CIBERSORT" algorithm was conducted to estimate immune cells infiltration abundance, with "ggplot2" package visualizing the results. In vivo and vitro experiments were used to verify the speculations of bioinformatics analysis. Results: In LGG patients, DNTTIP1/2 were over-expressed at mRNA levels and high DNTTIP1/2 levels correlated with poor survival in LGG patients. We confirmed that DNTTIP2 significantly promotes M2 macrophage activation and angiogenesis, which may be related to the IL6/JAK/STAT3 signaling pathway. In addition, we found that DNTTIP2 amplification was associated with an unfavorable prognosis in LGG patients. We demonstrated, finally, a correlation between DNTTIP2 gene hypermethylation and a poor prognosis in LGG. Conclusion: This study demonstrated that DNTTIP1/2 had diagnostic and prognostic value in LGG patients. The biological mechanisms of DNTTIP2 regarding angiogenesis and macrophage activation may provide new insights into the treatment of glioma. Keywords: low-grade glioma, DNTTIP2 , angiogenesis, M2 macrophages infiltration, bioinformatics Glioma is the most frequent central nervous system malignancy. 1 The World Health Organization (WHO) classification divides glioma into four grades (grades I–IV). 2 Low-grade gliomas (LGGs) are defined as diffuse low- and moderate-grade gliomas (WHO grades II and III). Because of its high malignancy and high degree of recurrence, LGG may rapidly progress to glioblastoma (GBM). 3 Despite a significant amount of effort devoted to LGG research, specifics of its pathogenesis remain unclear and there have been no breakthroughs made in its treatment, usually surgery followed by post-operative radiotherapy and chemotherapy. Therefore, research into the pathogenesis of glioma and early diagnosis of glioma is particularly important. With the rise of bioinformatics and high-throughput sequencing technologies, some progress has been made in identifying molecular markers related to LGG progression which can be used to predict prognosis and also a patient's response to personalized treatment. Deoxynucleotidyl transferase terminal-interacting proteins 1/2 ( DNTTIP1/2 ) were initially identified as regulators of terminal deoxynucleotidyl transferase (TDT), which plays a role in transcription regulation. DNTTIP1/2 is homologous to the transcription factor p65/NF-κB and acts on the histone deacetylases 1 and 2 (HDAC1 and HDAC2). 4,5 Epigenetic changes have been discovered in all stages of cancer progression 6 and histone acetylation is one of the most studied epigenetic regulatory pathways. Histone deacetylases (HDACs) are closely related to cancer occurrence and progression, and p53 deacetylation has been reported to be associated with the failure of cancer suppre -Abstract Truncated-
pharmacology & pharmacy